Literature DB >> 24391379

Serelaxin, a 'breakthrough' investigational intravenous agent for acute heart failure.

Marta A Miyares, Kyle A Davis.   

Abstract

Recombinant relaxin (serelaxin), a breakthrough therapy for acute heart failure.

Entities:  

Year:  2013        PMID: 24391379      PMCID: PMC3875246     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  25 in total

1.  Design of the RELAXin in acute heart failure study.

Authors:  Piotr Ponikowski; Marco Metra; John R Teerlink; Elaine Unemori; G Michael Felker; Adriaan A Voors; Gerasimos Filippatos; Barry Greenberg; Sam L Teichman; Thomas Severin; Guenther Mueller-Velten; Gad Cotter; Beth A Davison
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

2.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

3.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

4.  Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Authors:  John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana R Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas M Severin; Marco Metra
Journal:  Lancet       Date:  2012-11-07       Impact factor: 79.321

5.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

6.  Trends in death attributed to heart failure over the past two decades in Europe.

Authors:  Said Laribi; Albertine Aouba; Maria Nikolaou; Johan Lassus; Alain Cohen-Solal; Patrick Plaisance; Gérard Pavillon; Preeti Jois; Gregg C Fonarow; Eric Jougla; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2012-01-10       Impact factor: 15.534

7.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.

Authors:  Marco Metra; Christopher M O'Connor; Beth A Davison; John G F Cleland; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Michael M Givertz; George A Mansoor; Daniel M Bloomfield; Gang Jia; Paul DeLucca; Barry Massie; Howard Dittrich; Gad Cotter
Journal:  Eur Heart J       Date:  2011-03-08       Impact factor: 29.983

Review 8.  Recombinant relaxin: a review of pharmacology and potential therapeutic use.

Authors:  E S Gavino; D E Furst
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

9.  Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.

Authors:  Marco Metra; John R Teerlink; G Michael Felker; Barry H Greenberg; Gerasimos Filippatos; Piotr Ponikowski; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Beth Davison Weatherley; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2010-08-22       Impact factor: 15.534

Review 10.  Vasodilators in the treatment of acute heart failure: what we know, what we don't.

Authors:  Marco Metra; John R Teerlink; Adriaan A Voors; G Michael Felker; Olga Milo-Cotter; Beth Weatherley; Howard Dittrich; Gad Cotter
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

View more
  1 in total

1.  MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.

Authors:  Lei Xu; Cecelia C Yates; Pamela Lockyer; Liang Xie; Ariana Bevilacqua; Jun He; Cynthia Lander; Cam Patterson; Monte Willis
Journal:  J Mol Cell Cardiol       Date:  2014-10-01       Impact factor: 5.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.